Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-14 · accession 0001415889-23-002649 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-15 | 2023-02-14 | CAPR | COLLIER EARL M JR | Dir | M - OptEx | $1.39 | +1,401 | 16.9K | +9% | +$1,947 |
| D | 2023-02-15 | 2023-02-14 | CAPR | COLLIER EARL M JR | Dir | M - OptEx | $0.00 | -1,401 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 1,401 | $1.39 | 16,856 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-14 | M | D | 1,401 | $0.00 | 0 | D | $1.39 · — to 2023-02-22 | 1,401 Common Stock | (F1) This option was granted on February 22, 2013 and was previously reported as covering 14,015 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F2) 25% of the shares vested immediately, with the remainder vesting monthly over 25 months commencing May 1, 2013. |